NCT01423305View on ClinicalTrials.gov

Phase I Pharmacokinetic Study (BF-BLOCK)

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Asthma
Interventions
DRUG

Budesonide/formoterol capsule.

Oral administration with concomitant charcoal.

DRUG

Budesonide/formoterol capsule for oral adm.

Oral administration without concomitant charcoal.

Trial Locations (1)

20520

Clinical Reseach Services Turku (CRST), Turku

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT01423305 - Phase I Pharmacokinetic Study (BF-BLOCK) | Biotech Hunter | Biotech Hunter